Amphastar Pharmaceuticals (AMPH) Change in Acquisitions & Divestments (2016 - 2026)

Amphastar Pharmaceuticals has reported Change in Acquisitions & Divestments for 9 years, with the latest figure at $64.3 million in Q2 2026.

• On a quarterly basis, Change in Acquisitions & Divestments rose 179.23% year-over-year to $64.3 million in Q2 2026; TTM through Jun 2026 was $118.8 million, a 85.4% increase from a year earlier, with the FY2025 full-year figure at $90.3 million, down 28.35% from the prior year.
• Change in Acquisitions & Divestments was $64.3 million for Q2 2026 at Amphastar Pharmaceuticals, up from $15.5 million in the prior quarter.
• The five-year high for Change in Acquisitions & Divestments was $65.8 million in Q2 2024, with the low at -$179000.0 in Q4 2023.
• Average Change in Acquisitions & Divestments over 5 years is $20.2 million, with a median of $13.9 million recorded in 2023.
• The sharpest annual moves came in 2023 and 2024: Change in Acquisitions & Divestments plunged 101.43% in 2023, then surged 4281.01% in 2024.
• Over 5 years, Change in Acquisitions & Divestments stood at $12.5 million in 2022, then plunged by 101.43% to -$179000.0 in 2023, then soared by 4281.01% to $7.5 million in 2024, then surged by 119.7% to $16.4 million in 2025, then surged by 291.18% to $64.3 million in 2026.
• The last three Change in Acquisitions & Divestments figures came in at $64.3 million (Q2 2026), $15.5 million (Q1 2026), and $16.4 million (Q4 2025), per Business Quant data.